 SEATTLE--BUSINESS WIRE--Alpine Immune Sciences, Inc. NASDAQ: ALPN, a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced that members of its management team will present at the following investor conferences in January 2022: H.C. Wainwright BIOCONNECT Virtual Conference Date: Monday, January 10, 2022 Time: Available on demand beginning 7:00 a.m. ET4:00 a.m. PT Event: Company Presentati 